Nicholas Verity

2.8k total citations · 2 hit papers
12 papers, 2.0k citations indexed

About

Nicholas Verity is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Nicholas Verity has authored 12 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Physiology. Recurrent topics in Nicholas Verity's work include Prion Diseases and Protein Misfolding (9 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and RNA regulation and disease (4 papers). Nicholas Verity is often cited by papers focused on Prion Diseases and Protein Misfolding (9 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and RNA regulation and disease (4 papers). Nicholas Verity collaborates with scholars based in United Kingdom, Netherlands and United States. Nicholas Verity's co-authors include Giovanna R. Mallucci, Helois Radford, Julie A. Moreno, Mark Halliday, David A. Barrett, Anne E. Willis, Catharine A. Ortori, Colin Molloy, Peter M. Fischer and Martin Bushell and has published in prestigious journals such as Nature, Nature Communications and Neuron.

In The Last Decade

Nicholas Verity

12 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sustained translational repression by eIF2α-P mediates prion neurodegeneration

2012 489 citations Julie A. Moreno, Helois Radford et al. Nature profile →
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

2013 453 citations Julie A. Moreno, Mark Halliday et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Verity United Kingdom	11	1.2k	932	521	388	346	12	2.0k
Helois Radford United Kingdom	11	1.3k 1.1×	921 1.0×	489 0.9×	379 1.0×	315 0.9×	12	2.1k
Mark Halliday United Kingdom	11	1.1k 0.9×	859 0.9×	429 0.8×	376 1.0×	297 0.9×	14	1.8k
Jacqueline A. Sluijs Netherlands	22	1.4k 1.1×	359 0.4×	694 1.3×	211 0.5×	471 1.4×	42	2.4k
Tommy L. Lewis United States	20	1.8k 1.5×	382 0.4×	470 0.9×	379 1.0×	756 2.2×	28	2.6k
Melissa J. Alldred United States	23	1.1k 0.9×	298 0.3×	593 1.1×	233 0.6×	467 1.3×	39	2.0k
Rand Posmantur United States	21	1.3k 1.1×	706 0.8×	290 0.6×	437 1.1×	525 1.5×	26	2.4k
Bruno Gasnier France	25	1.1k 0.9×	558 0.6×	406 0.8×	239 0.6×	598 1.7×	37	2.2k
Jonathon L. Burman United States	12	2.2k 1.8×	583 0.6×	506 1.0×	1.8k 4.6×	593 1.7×	14	3.6k
Ruth E. Thomas United States	12	1.2k 1.0×	448 0.5×	422 0.8×	855 2.2×	368 1.1×	17	2.2k
J. Alex Parker Canada	25	1.3k 1.1×	287 0.3×	494 0.9×	290 0.7×	578 1.7×	51	2.5k

Countries citing papers authored by Nicholas Verity

Since Specialization

Citations

This map shows the geographic impact of Nicholas Verity's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Verity with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Verity more than expected).

Fields of papers citing papers by Nicholas Verity

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Verity. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Verity. The network helps show where Nicholas Verity may publish in the future.

Co-authorship network of co-authors of Nicholas Verity

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Verity. A scholar is included among the top collaborators of Nicholas Verity based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Verity. Nicholas Verity is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bradford, Barry, et al.. (2024). Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease. Scientific Reports. 14(1). 13749–13749. 3 indexed citations

Seo, Sang Soo, Susana R. Louros, Miguel A. Gonzalez‐Lozano, et al.. (2022). Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome. Nature Communications. 13(1). 3236–3236. 30 indexed citations

Peretti, Diego, Heather Smith, Nicholas Verity, et al.. (2021). TrkB signaling regulates the cold-shock protein RBM3-mediated neuroprotection. Life Science Alliance. 4(4). e202000884–e202000884. 22 indexed citations

Smith, Heather, Oliver Freeman, Adrian J. Butcher, et al.. (2020). Astrocyte Unfolded Protein Response Induces a Specific Reactivity State that Causes Non-Cell-Autonomous Neuronal Degeneration. Neuron. 105(5). 855–866.e5. 149 indexed citations

Hughes, Daniel T., Mark Halliday, Heather Smith, et al.. (2020). Targeting the kinase insert loop of PERK selectively modulates PERK signaling without systemic toxicity in mice. Science Signaling. 13(644). 13 indexed citations

Halliday, Mark, Helois Radford, Colin Molloy, et al.. (2017). Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. Brain. 140(6). 1768–1783. 213 indexed citations

Radford, Helois, Julie A. Moreno, Nicholas Verity, Mark Halliday, & Giovanna R. Mallucci. (2015). PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathologica. 130(5). 633–642. 222 indexed citations

Peretti, Diego, Amandine Bastide, Helois Radford, et al.. (2015). RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration. Nature. 518(7538). 236–239. 181 indexed citations

Halliday, M.S., Helois Radford, Yusuke Sekine, et al.. (2015). Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death and Disease. 6(3). e1672–e1672. 258 indexed citations

10.

Moreno, Julie A., Mark Halliday, Colin Molloy, et al.. (2013). Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice. Science Translational Medicine. 5(206). 206ra138–206ra138. 453 indexed citations breakdown →

11.

Moreno, Julie A., Helois Radford, Diego Peretti, et al.. (2012). Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature. 485(7399). 507–511. 489 indexed citations breakdown →

12.

Verity, Nicholas & Giovanna R. Mallucci. (2010). Rescuing neurons in prion disease. Biochemical Journal. 433(1). 19–29. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact